World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

ASSESSMENT OF ETIOLOGY, RISK FACTORS, COMPLICATIONS AND TREATMENT ASSOCIATED WITH DIFFERENT ATTACKS OF URINARY TRACT INFECTION

Dr. Haripriya Simha*, Dr. N. Hema Sri Lakshmi, Dr. Y. Spandana, Dr. S. Yoga Sree, Dr. G.N.S. Santoshi Lakshmi

ABSTRACT

Aim: To ascertain the etiology, risk factors, complications and reoccurrence in patients with Urinary Tract Infection. Result: Total 150 patients were included in the study. out of then 130 patients were diagnosed with UTI Like in most of the studies on UTI, female patients in our study are significantly higher (58.66%) than male patients (41.33%).Bacteria (86.66%) was found to be most prevalant cause of UTI, followed by Fungi (10%) and viruses (3.33%). Among the risk factors, Medical risk factors (58.91%) were predominant in the development of UTI, followed by common risk factors (28.37%) and Medication risk factors (12.66%). Among the medicational risk factors, use of Immuno suppressant drugs was identified as the leading risk factor found in 24% (36 out of 150), of study population accompanied by use of calcium channel blockers 14.66%, use of muscle relaxants 1.33% and use of anti histamines 2.66% having similar significant impact. 78.66% of the patients had complications. Kidney failure were predominantly seen in 26.66%, followed by Pyelonephritis and Urosepsis with 18%, AGN with 7.33%, Haemorrhagic cystitis with 4.66%, Abscess formation near kidneys with 2.66%, Xanthogranulomatous pyelonephritis(1.33%). Concomitant conditions were found in 70% of patients with complications.51 patients are found to be recurrent attacks of UTI. Bacterial UTI is commonly treated with ceftriaxone (45%), followed by Piperacillin+ Tazobactum and ciprofloxacin with 12%. Patients with Recurrent attacks were found to be treated frequently with Piperacillin+Tazobactum (24.3%), accompained by Nitrofurantoin with 9.3%.Fungal UTI, patients with first attack were found to be treated with fluconazole(3.33%) and patients of recurrent fungal UTI were treated with AmphotericinB. In viral UTI, patients were found to be treated with cidofovir with 3.33%.and got significant values in student T test using spss software. Conclusion: In our study we concluded that females were more prone to develop UTI than males. Incidence of UTI was high in age group 0-15 yrs and in rural patients. Bacteria was identified as a major cause of UTI. In bacteria, E.coli is major cause of the bacterial UTI. Fever with chills and rigors are identified as a most experienced symptom in almost all patients. Medical risk factors was identified as a major risk factors indicating that constipation plays a dominant role for development of UTI. The impact of concomitant conditions in compliacating UTI has been observed in our study. Nephrotic syndrome is the condition associated with UTI in majority of the patients. More than three-fourth of the patients had complications indicating that kidney failure is found to be greater extent with in 6-12 months, followed by pyelonephritis with in 0-3 months after development of UTI. 51 patients were being experiencing with recurrent UTI attacks, in which 2nd attack of UTI patients were predominant. Recurrent UTI was found in majority of the patients with most of them having untreated kidney stones followed by hydroureteronephrosis. Ceftriaxone was majorly used first line drug in uncomplicated UTI, while Piperacillin+Tazobactum was majorly used in recurrent attack followed by Nitrofurantoin. In our study, we have found 5 drug interactions were significant drug interaction while other 2 are moderate interactions and 5 ADRS were observed.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR